Endonovo Therapeutics Inc (ENDV) Annual Balance Sheets

Annual · GAAP · USD millions
Access ENDV quarterly Balance Sheets →
Balance sheet data covering Endonovo Therapeutics Inc–Dec 31 2018 offers a view into how Dec 31 2022's financial position has changed alongside business activity.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2022)
(Dec 31 2021) (Dec 31 2020) (Dec 31 2019) (Dec 31 2018)
Assets
Cash & cash equivalent0.00
Cash & Short-term Investments0.00
Accounts receivable0.00
Prepaid Expense And Other Assets Current0.02
Total Current Assets0.02
Equipment/Property/Plant Net0.00
Intangible Assets1.27
Other Assets, Noncurrent0.00
Total Assets1.28
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.88
Interest Payable, Current IN3.54
Derivative Liability, Current DE17.36
Notes Payable, Current NO7.04
Other Liabilities, Current0.11
Deferred Compensation Liability, Current LI4.44
Total Current Liabilities33.38
Long-term debt0.00
Long-term Debt Convertible0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.08
Total Liabilities33.46
Stockholders' Equity
Convertible Preferred Stock Value-
Common Stock Value0.02
Common Stock, Held by Subsidiary etc.-
Additional Paid In Capital Common Stock42.92
Retained Earnings / Accumulated Deficit-75.12
Other Equity0.00
Common Stockholder's Equity-32.18
Preferred Stockholder's Equity0.00
Non-controlling interests & other0.00
Total Stockholder's Equity-32.18
Liabilities & Stockholder's Equity1.28
4 historic quarters locked

Sign in to unlock the full Endonovo Therapeutics Inc balance sheet history.

About Endonovo Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-23-046561

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.